1. Home
  2. BYND vs TLSA Comparison

BYND vs TLSA Comparison

Compare BYND & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYND
  • TLSA
  • Stock Information
  • Founded
  • BYND 2009
  • TLSA 2013
  • Country
  • BYND United States
  • TLSA United Kingdom
  • Employees
  • BYND N/A
  • TLSA N/A
  • Industry
  • BYND Packaged Foods
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYND Consumer Staples
  • TLSA Health Care
  • Exchange
  • BYND Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • BYND 214.6M
  • TLSA 187.0M
  • IPO Year
  • BYND 2019
  • TLSA 2000
  • Fundamental
  • Price
  • BYND $2.73
  • TLSA $1.66
  • Analyst Decision
  • BYND Sell
  • TLSA
  • Analyst Count
  • BYND 4
  • TLSA 0
  • Target Price
  • BYND $3.00
  • TLSA N/A
  • AVG Volume (30 Days)
  • BYND 2.0M
  • TLSA 325.5K
  • Earning Date
  • BYND 11-05-2025
  • TLSA 05-06-2025
  • Dividend Yield
  • BYND N/A
  • TLSA N/A
  • EPS Growth
  • BYND N/A
  • TLSA N/A
  • EPS
  • BYND N/A
  • TLSA N/A
  • Revenue
  • BYND $301,353,000.00
  • TLSA N/A
  • Revenue This Year
  • BYND N/A
  • TLSA N/A
  • Revenue Next Year
  • BYND $0.73
  • TLSA N/A
  • P/E Ratio
  • BYND N/A
  • TLSA N/A
  • Revenue Growth
  • BYND N/A
  • TLSA N/A
  • 52 Week Low
  • BYND $2.23
  • TLSA $0.63
  • 52 Week High
  • BYND $7.60
  • TLSA $2.60
  • Technical
  • Relative Strength Index (RSI)
  • BYND 52.75
  • TLSA 43.10
  • Support Level
  • BYND $2.29
  • TLSA $1.63
  • Resistance Level
  • BYND $2.60
  • TLSA $1.88
  • Average True Range (ATR)
  • BYND 0.14
  • TLSA 0.15
  • MACD
  • BYND 0.06
  • TLSA -0.01
  • Stochastic Oscillator
  • BYND 80.73
  • TLSA 38.46

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: